YEXABLE Trademark

Trademark Overview


On Monday, April 13, 2020, a trademark application was filed for YEXABLE with the United States Patent and Trademark Office. The USPTO has given the YEXABLE trademark a serial number of 88869570. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Eli Lilly and Company. The YEXABLE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
yexable

General Information


Serial Number88869570
Word MarkYEXABLE
Filing DateMonday, April 13, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
Translation of Words in MarkThe wording "YEXABLE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021SOU EXTENSION 2 GRANTED
Friday, July 16, 2021SOU EXTENSION 2 FILED
Friday, July 16, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2021SOU EXTENSION 1 GRANTED
Friday, January 22, 2021SOU EXTENSION 1 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 22, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, May 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 9, 2020ASSIGNED TO EXAMINER
Tuesday, April 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 16, 2020NEW APPLICATION ENTERED